Cancer Survivorship · Collection 05

Cancer Treatment Ended. So Why Don’t I Feel Like Myself Again?

What survivorship can mean for menopause, bladder and vaginal health, sexuality, sleep, bones, and the body you came home to.

The clinical education

Cancer-free does not automatically mean symptom-free.

Surviving cancer and feeling well after cancer are not the same clinical outcome. Cancer, its treatment, and sometimes long-term therapy can affect several parts of health at once. The effects differ by cancer type, treatment, age, other health conditions, and the person. They are possible, not inevitable, and they deserve care when they occur.

Survivorship is not a brief interval after the last infusion. It can include life during treatment, after treatment ends, and while a person takes long-term medication. Changes may show up in menopause, sleep, bladder or vaginal health, sexual function, pelvic-floor coordination, bones, muscles and joints, energy, cognition, body composition, mood, or body image. Some are treatment effects; some reflect aging, another medical condition, stress, or several things together.

“Surviving cancer and feeling well after cancer are not the same clinical outcome.”

When menopause begins because of cancer treatment

Menopause after cancer treatment may arrive differently from a gradual natural transition. Chemotherapy can impair ovarian function; ovarian-suppression medicines can temporarily or persistently quiet ovarian function; surgery to remove both ovaries causes menopause; radiation that affects the ovaries may cause ovarian insufficiency; and endocrine therapies can produce or intensify menopause symptoms. The effect depends on the treatment and on whether ovarian function returns. Some changes begin abruptly, while others develop during ongoing therapy.

“The menopause may be medically induced. The symptoms are still real.”

Hot flashes, night sweats, disrupted sleep, vaginal or urinary changes, sexual pain, shifts in desire, mood changes, joint symptoms, and bone loss may accompany low-estrogen states or particular treatments. Those symptoms are not proof of recurrence, but a cancer history also does not mean every new symptom should be explained away as menopause.

Hormone therapy is not one decision for every cancer survivor

“You can’t take hormones” can shut down a conversation before the actual question is clear. The safety discussion depends on the cancer type and biology, hormone-receptor status when relevant, prior and current treatment, recurrence-risk considerations, the symptom being treated, the specific therapy and route, evidence and uncertainty, other medicines, personal goals, and whether oncology input is needed.

Systemic menopausal hormone therapy reaches the whole body and is a different decision from a low-dose local vaginal therapy for genitourinary symptoms. After breast cancer, systemic hormone therapy is generally avoided, particularly for estrogen-responsive disease. The recent general labeling changes for menopause hormone-therapy products do not erase this cancer-specific risk discussion. Low-dose vaginal estrogen may be considered for persistent GSM symptoms in selected breast-cancer survivors after nonhormonal measures and an informed conversation; when a person is taking an aromatase inhibitor, shared decision-making with the oncology team is especially important. Nonhormonal treatments are also available. Other cancers cannot all be grouped under the same rule: tumor type, site, pathology, treatment, and goals matter. No survivor should be promised universal safety or told that every possible treatment is forbidden.

For the focused breast-cancer discussion, see Breast Cancer/Menopause Care. That collection addresses breast-cancer-specific decisions in depth; this one looks across the wider survivorship picture.

Vaginal, vulvar, bladder, and sexual changes belong in survivorship care

Low-estrogen states and some cancer treatments can change vulvovaginal and lower urinary tissues. Dryness, irritation, burning, tissue tenderness, painful penetration, urinary urgency or frequency, dysuria, and recurrent urinary symptoms can occur. Some women also develop recurrent bacterial UTIs. Similar symptoms can have different causes, and more than one cause can coexist.

“Urinary symptoms after cancer treatment are not automatically an infection.”

A urine culture can help answer whether bacteria are present; it does not assess GSM, vulvar skin conditions, pelvic-floor muscle pain, or bladder pain syndrome. Conversely, a cancer history should not be used to skip appropriate infection testing or evaluation. Explore Negative Urine Culture, Recurrent UTI, Urgency, Frequency & Nocturia, Vulvar Burning, and Painful Sex for those specific concerns.

Sexual health is also part of health after cancer. Comfort, vaginal tissue, pelvic-floor function, desire, arousal, orgasm, body image, confidence, and relationship dynamics may change. Some women want partnered sex, some do not; some have partners, some do not; some want help with sexual activity and some want help feeling comfortable in their bodies. Care should begin with what the woman herself wants, never an assumption about a partner, orientation, penetration, or a required level of desire. Related collections include Sexual Desire/Libido and Testosterone and Sexual Health.

Bone, muscle, energy, and concentration can be part of the same story

Some treatments can increase bone-loss risk. Examples include ovarian suppression or treatment-induced menopause, aromatase inhibitors, glucocorticoids used in some cancer regimens, and other treatment-specific effects. A survivor’s risk depends on the exposure and the rest of her fracture-risk profile. She may need earlier or closer attention than routine age-based screening alone would suggest, but not every survivor needs the same DXA schedule or medication.

Depending on treatment, women may also experience fatigue, cognitive complaints, body-composition changes, muscle loss, joint or other musculoskeletal symptoms, neuropathy, emotional strain, and changes in body image. These concerns can reinforce one another: pain can disturb sleep; poor sleep can worsen fatigue and concentration; inactivity can affect strength and balance; and hot flashes can compound an already fragile night. Related StrongHer Care collections include Bone Health, Sleep, and Body Composition. Our hormone-levels collection also discusses symptoms such as concentration changes in the broader midlife picture.

The StrongHer truth

“Cancer-free does not automatically mean symptom-free.” A symptom does not need to threaten survival before it deserves a careful assessment and a plan.

A composite experience

“Everyone was celebrating that treatment was over. I was wondering what happened to my body.”

This composite vignette reflects experiences women may describe after cancer treatment. It is not the story of one identifiable patient, and no single survivor has every symptom in it.

Her family was relieved. Her friends called her brave. She was grateful that treatment had worked, and she was still waking drenched in sweat. She could not remember the last time she slept through the night. Her joints hurt. Her body had changed. She struggled to concentrate through a conversation and worried that her bones were thinning.

When she said sex hurt now, she felt disloyal to the people who had helped save her life. “My oncologist saved my life. I don’t want to sound ungrateful.” Another day, she wondered if she had a UTI again. The culture was negative. The burning was not. She thought, “I survived. Why don’t I feel like myself?”

“I keep thinking I have UTIs.” · “My hot flashes are unbearable.” · “My body changed.” · “I can’t concentrate the way I used to.”

Gratitude and struggle can live in the same body. Naming pain, exhaustion, vaginal symptoms, fear, or loss of confidence does not diminish survival or the people who helped make it possible. She does not have to accept every symptom as the price of being alive, and she does not need to wait until she has the right words to ask for help.

What helped was a clinician who listened across the whole story: what cancer she had, which treatments she received, what was still ongoing, when symptoms began, what had been tried, and what she most wanted back. The first step was not a promise or a prohibition. It was taking her symptoms seriously enough to understand them.

Where women see themselves

You can be grateful for treatment and still want relief. Asking to feel more comfortable, rested, strong, connected, or like yourself is not ingratitude. It is part of caring for the life you came home to.

Dr. Rhaney’s perspective

When a cancer survivor tells me she doesn’t feel like herself, I don’t hear one symptom. I start looking at the whole system.

I begin with the cancer and its treatment because those details can change what is safe and useful. Then I ask what has changed in the woman’s daily life and what matters most to her now.

What cancer did she have? What treatment did she receive, and is treatment ongoing? Was menopause natural, treatment-induced, or still uncertain? Is she taking endocrine therapy? Which symptom is most disruptive: hot flashes, sleep, GSM, urinary symptoms, sexual concerns, pelvic-floor symptoms, bone risk, muscle or joint symptoms, cognition, fatigue, mood, or a medication effect? What has already been tried? What does she want help with first? Where is collaboration with oncology important?

“When a cancer survivor tells me she doesn’t feel like herself, I don’t hear one symptom. I start looking at the whole system.”

A symptom inventory can help us notice patterns, but it is an invitation to ask, not a mandatory checklist that every survivor must complete. For one woman, sleep and hot flashes may be the priority. For another, bladder symptoms, painful sex, a fracture, fatigue, or distress about body changes may be the reason she came. The goal is to find out what is happening and what she wants addressed, not to turn survivorship into an endless list of deficits.

Sometimes what is missing is someone seeing how the pieces connect. The answer is not always another referral. When another clinician is needed, their role should be clear and the handoff should support one plan. Oncology remains essential for cancer-specific surveillance and cancer treatment decisions. Long-term symptoms may also be addressed by primary care, gynecology or menopause care, urogynecology, sexual medicine, pelvic-floor physical therapy, bone-health specialists, rehabilitation, mental-health care, or other disciplines based on the person’s needs.

The StrongHer truth

“Coordinated care does not mean sending a woman to six specialists who never talk to one another.” It means the right expertise contributes to care that remains centered on her.

Felicia L. Rhaney, MD, FACOG, MSCP
Double board-certified OB-GYN and urogynecologist

The survivorship guide

Survivorship care should ask more than whether the cancer came back. It should also ask how the woman is living.

Start with the symptom that is affecting her life. Then connect that concern to the cancer history, evaluate plausible causes, and build a plan that respects both cancer-specific safety and the person’s priorities.

Identify what changed

Choose the parts of a symptom inventory that fit her concerns: menopause symptoms; sleep; vaginal or vulvar symptoms; bladder symptoms; sexual function; pelvic-floor symptoms; bone health; muscles and joints; cognition; fatigue; body composition or metabolic health; and emotional well-being. Ask when each change began and how it affects daily life. This is a guide for a conversation, not a universal checklist.

Treat menopause symptoms individually

For bothersome hot flashes and night sweats, evidence-based nonhormonal options may include cognitive behavioral therapy, clinical hypnosis, selected SSRIs or SNRIs, gabapentin, fezolinetant, or oxybutynin, depending on the person and the symptom. Check medication interactions, including CYP2D6-inhibiting antidepressants when tamoxifen is used; consider side effects, health conditions, and current prescribing guidance. If hormone therapy is considered, distinguish systemic from local treatment and account for cancer-specific risks. Do not start or stop endocrine therapy to manage symptoms without the oncology team.

Don’t abandon GSM

First clarify the symptoms and examine for causes such as GSM, skin disease, infection, pelvic-floor pain, or another condition. Vaginal moisturizers used regularly can support ongoing comfort; lubricants reduce friction during sexual activity. They do not treat every underlying tissue change. Pelvic-floor physical therapy may help when muscle overactivity, tenderness, or coordination problems contribute. Local vaginal estrogen and other local or nonestrogen therapies may be considered when appropriate, with choice matched to the diagnosis, evidence, prior treatment, and the woman’s goals. Options such as vaginal DHEA (prasterone) or ospemifene have their own evidence and labeling cautions in some cancer contexts; they are not automatically safer substitutes for every survivor.

Make cancer-specific shared decisions about local therapy

For a history of estrogen-dependent breast cancer, guidelines support beginning with nonhormonal options. If symptoms remain troublesome, low-dose vaginal estrogen can be considered for selected patients after discussion of benefits, uncertainties, and alternatives. For someone taking an aromatase inhibitor, include the oncologist in shared decision-making when appropriate. Systemic menopausal hormone therapy is a separate question and is generally avoided after breast cancer, especially hormone-responsive disease. Other cancer histories require their own pathology- and treatment-specific assessment. “Nothing hormonal ever” and “safe for every survivor” are both too absolute.

Protect sexual health and bone health

Sexual care may address tissue symptoms, pain, pelvic-floor dysfunction, medication effects, desire or arousal concerns, body image, and relationship or life context. The plan belongs to the woman and her goals; one intervention rarely solves every contributor. Explore Painful Sex, Sexual Desire/Libido, Vulvar Burning, and Testosterone/Sexual Health for focused conversations. For bone health, consider treatment exposure, menopause timing, prior fracture, age, medications such as glucocorticoids, and overall risk when deciding about DXA timing and repeat testing. Discuss adequate calcium and vitamin D, progressive resistance and weight-bearing activity as appropriate, fall-risk reduction, and osteoporosis medication when indicated. Follow Bone Health for the full fracture-risk discussion.

Connect sleep, muscle, and metabolic health

Hot flashes, pain, nocturia, mood, medication effects, and sleep disorders can all disturb sleep. Fatigue and interrupted sleep may make movement harder; loss of strength or conditioning can affect function and balance. Body-composition changes and musculoskeletal symptoms can be related to treatment, menopause, activity, other conditions, or several factors. Use the existing StrongHer Care collections on Sleep and Body Composition for deeper discussion. Related concerns such as concentration changes appear in the hormone-levels collection. Evaluate muscle or cognitive complaints on their own merits rather than assuming one cause.

Coordinate with oncology without making oncology responsible for everything

Oncology leads cancer-specific surveillance and treatment decisions. Depending on the issue, primary care, gynecology or menopause care, urogynecology, sexual medicine, pelvic-floor physical therapy, bone health, rehabilitation, or mental-health care may be appropriate partners. Agree on who is doing what, share the relevant treatment history, and keep the plan connected to the woman’s priorities.

When survivorship symptoms need a closer look

Not every new symptom should automatically be attributed to menopause, treatment, or survivorship. It may call for assessment for recurrence, a new condition, a treatment complication, or an unrelated illness. The right response depends on her cancer type, treatments, timing, and symptom pattern. New unexplained bleeding, a new mass or tissue change, persistent focal pain without a clear explanation, significant unintentional weight loss, new neurologic symptoms, concerning cardiopulmonary symptoms, or severe or rapidly changing symptoms deserve prompt clinical attention. Cancer-specific warning signs differ; this is not one generic recurrence checklist. Prompt evaluation is a way to understand what is happening, not a prediction that cancer has returned.

Questions that can move the conversation forward

Could my cancer or treatment explain this symptom, and what else should be considered?
What is the most important problem for me to address first?
Does my current or past endocrine therapy change the options?
What nonhormonal and local treatments fit this particular symptom?
Would oncology input improve this decision, and who will coordinate the plan?
What would improvement look like to me, and when will we reassess?

Myths that can leave women without care

“I should just be grateful I’m alive.” Gratitude and distress can coexist. Symptoms that affect quality of life deserve attention.
“Treatment is over, so my body should be back to normal.” Recovery is not a reset button. Some effects may continue, emerge later, or be related to long-term treatment.
“Cancer survivors can’t receive menopause treatment.” Options depend on cancer biology, treatment, symptom, therapy type, and individual risk. There is no single answer for all cancers or all treatments.
“Vaginal symptoms aren’t important compared with cancer.” Comfort, bladder health, and sexual well-being are legitimate parts of health after cancer.
“Painful sex is just the price of survivorship.” Pain deserves assessment. GSM, pelvic-floor dysfunction, skin conditions, treatment effects, and other causes may need different approaches.
“Every urinary symptom is a UTI.” Infection is one possibility. Urine testing and the broader symptom pattern help distinguish it from GSM, vulvar or pelvic-floor conditions, and other causes.
“Bone loss is something to worry about only when I’m old.” Some cancer treatments and early menopause can change bone risk well before the usual screening age.
“My oncologist has to manage every long-term symptom.” Oncology is essential for cancer-specific care; other clinicians may be better positioned to treat particular long-term effects, in coordination with oncology as needed.
“If my cancer surveillance is normal, every other symptom must be harmless.” Reassuring surveillance is good news, but new symptoms still need the evaluation appropriate to the person and her history.

The life after cancer deserves care, too

“They treated my cancer. I am allowed to ask for help treating the life I am living afterward.”

Important: This education is not an individualized diagnosis or treatment plan. Cancer-specific surveillance, hormone-related decisions, prescription changes, and evaluation of new symptoms should be discussed with qualified clinicians who know the person’s cancer and treatment history.

Clinical review

Educational content reviewed September 2026 by Felicia L. Rhaney, MD, FACOG, MSCP. This material supports, but does not replace, individualized evaluation and care.

Selected guidance

Continue exploring

One topic. A fuller conversation.

Return to The Knowledge Hub

Survivorship is about more than surveillance. It is also about the life she is living now.